Plain-English translation of NCT07220876 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new device called the VisiPlate Aqueous Shunt, which is a small implant placed in the eye to help drain fluid and lower eye pressure. The trial is for people with open-angle glaucoma — a condition where high eye pressure damages the optic nerve — who have already tried medicines and other surgeries without success. Researchers want to see whether this new shunt device is safe and whether it effectively controls eye pressure.
Some people with glaucoma don't respond well enough to eye drops or standard glaucoma surgeries, and their vision continues to decline. This trial exists to offer a new treatment option for these patients and to find out if the VisiPlate Aqueous Shunt can successfully lower eye pressure when other treatments have failed.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo surgery to have the VisiPlate Aqueous Shunt implanted in your eye. After the procedure, you will have follow-up visits to check how well the device is working, how your eye pressure responds, and whether you experience any side effects. The study will track your eye pressure, vision, and overall eye health over time to determine whether the treatment is safe and effective for controlling your glaucoma.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States